Wang Hui, Li Xiangyang, Shi Pengcheng, You Xiaoyan, Zhao Guoping
Master Lab for Innovative Application of Nature Products, National Center of Technology Innovation for Synthetic Biology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CAS), Tianjin, 300308, China.
Henan Engineering Research Center of Food Microbiology, College of Food and Bioengineering, Henan University of Science and Technology, Luoyang, 471023, China.
Mater Today Bio. 2024 May 5;26:101079. doi: 10.1016/j.mtbio.2024.101079. eCollection 2024 Jun.
As a booming engineering technology, the microfluidic chip has been widely applied for replicating the complexity of human intestinal micro-physiological ecosystems . Biosensors, 3D imaging, and multi-omics have been applied to engineer more sophisticated intestinal barrier-on-chip platforms, allowing the improved monitoring of physiological processes and enhancing chip performance. In this review, we report cutting-edge advances in the microfluidic techniques applied for the establishment and evaluation of intestinal barrier platforms. We discuss different design principles and microfabrication strategies for the establishment of microfluidic gut barrier models . Further, we comprehensively cover the complex cell types (e.g., epithelium, intestinal organoids, endothelium, microbes, and immune cells) and controllable extracellular microenvironment parameters (e.g., oxygen gradient, peristalsis, bioflow, and gut-organ axis) used to recapitulate the main structural and functional complexity of gut barriers. We also present the current multidisciplinary technologies and indicators used for evaluating the morphological structure and barrier integrity of established gut barrier models . Finally, we highlight the challenges and future perspectives for accelerating the broader applications of these platforms in disease simulation, drug development, and personalized medicine. Hence, this review provides a comprehensive guide for the development and evaluation of microfluidic-based gut barrier platforms.
Cell Mol Gastroenterol Hepatol. 2022
ACS Appl Mater Interfaces. 2021-3-31
Curr Pharm Des. 2018
Cell Mol Gastroenterol Hepatol. 2021
Acta Biomater. 2024-10-15
Biomater Transl. 2024-3-28
Front Bioeng Biotechnol. 2020-7-31
Mater Today Bio. 2025-6-6
Int J Mol Sci. 2025-5-4
Cell Prolif. 2025-4-26
Drug Deliv Transl Res. 2025-3-6
Adv Healthc Mater. 2024-8
Adv Sci (Weinh). 2024-5
Theranostics. 2024
Crit Rev Food Sci Nutr. 2025